nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—CYP1A1—prostate cancer	0.243	1	CbGaD
Fluorescein—ABCC1—Abiraterone—prostate cancer	0.0939	0.175	CbGbCtD
Fluorescein—ABCB11—Ethinyl Estradiol—prostate cancer	0.0852	0.159	CbGbCtD
Fluorescein—CYP1A1—Flutamide—prostate cancer	0.058	0.108	CbGbCtD
Fluorescein—ABCC1—Conjugated Estrogens—prostate cancer	0.0444	0.083	CbGbCtD
Fluorescein—CYP1A1—Estrone—prostate cancer	0.0419	0.0784	CbGbCtD
Fluorescein—ABCC1—Mitoxantrone—prostate cancer	0.0404	0.0754	CbGbCtD
Fluorescein—ABCC1—Epirubicin—prostate cancer	0.0327	0.0611	CbGbCtD
Fluorescein—ABCC1—Etoposide—prostate cancer	0.0255	0.0476	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—prostate cancer	0.0244	0.0457	CbGbCtD
Fluorescein—CYP1A1—Estradiol—prostate cancer	0.0241	0.045	CbGbCtD
Fluorescein—SLC22A6—Conjugated Estrogens—prostate cancer	0.024	0.0449	CbGbCtD
Fluorescein—ABCC1—Docetaxel—prostate cancer	0.0233	0.0435	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—prostate cancer	0.0174	0.0324	CbGbCtD
Fluorescein—Bradycardia—Prednisone—prostate cancer	9.28e-05	0.00065	CcSEcCtD
Fluorescein—Rash—Goserelin—prostate cancer	9.28e-05	0.000649	CcSEcCtD
Fluorescein—Dermatitis—Goserelin—prostate cancer	9.27e-05	0.000649	CcSEcCtD
Fluorescein—Vomiting—Conjugated Estrogens—prostate cancer	9.27e-05	0.000649	CcSEcCtD
Fluorescein—Urticaria—Estradiol—prostate cancer	9.27e-05	0.000649	CcSEcCtD
Fluorescein—Immune system disorder—Capecitabine—prostate cancer	9.25e-05	0.000647	CcSEcCtD
Fluorescein—Mediastinal disorder—Capecitabine—prostate cancer	9.23e-05	0.000646	CcSEcCtD
Fluorescein—Abdominal pain—Estradiol—prostate cancer	9.22e-05	0.000646	CcSEcCtD
Fluorescein—Headache—Goserelin—prostate cancer	9.22e-05	0.000645	CcSEcCtD
Fluorescein—Erythema—Docetaxel—prostate cancer	9.21e-05	0.000644	CcSEcCtD
Fluorescein—Rash—Conjugated Estrogens—prostate cancer	9.19e-05	0.000643	CcSEcCtD
Fluorescein—Chills—Capecitabine—prostate cancer	9.19e-05	0.000643	CcSEcCtD
Fluorescein—Dermatitis—Conjugated Estrogens—prostate cancer	9.18e-05	0.000643	CcSEcCtD
Fluorescein—Headache—Conjugated Estrogens—prostate cancer	9.13e-05	0.000639	CcSEcCtD
Fluorescein—Cardiac arrest—Doxorubicin—prostate cancer	9.07e-05	0.000635	CcSEcCtD
Fluorescein—Anaphylactic shock—Etoposide—prostate cancer	9.04e-05	0.000633	CcSEcCtD
Fluorescein—Dysgeusia—Docetaxel—prostate cancer	9.02e-05	0.000631	CcSEcCtD
Fluorescein—Feeling abnormal—Mitoxantrone—prostate cancer	8.96e-05	0.000627	CcSEcCtD
Fluorescein—Erythema—Capecitabine—prostate cancer	8.91e-05	0.000624	CcSEcCtD
Fluorescein—Asthma—Epirubicin—prostate cancer	8.91e-05	0.000624	CcSEcCtD
Fluorescein—Gastrointestinal pain—Mitoxantrone—prostate cancer	8.89e-05	0.000622	CcSEcCtD
Fluorescein—Tachycardia—Etoposide—prostate cancer	8.82e-05	0.000618	CcSEcCtD
Fluorescein—Skin disorder—Etoposide—prostate cancer	8.78e-05	0.000615	CcSEcCtD
Fluorescein—Nausea—Goserelin—prostate cancer	8.74e-05	0.000612	CcSEcCtD
Fluorescein—Hyperhidrosis—Etoposide—prostate cancer	8.74e-05	0.000612	CcSEcCtD
Fluorescein—Dysgeusia—Capecitabine—prostate cancer	8.73e-05	0.000611	CcSEcCtD
Fluorescein—Angina pectoris—Epirubicin—prostate cancer	8.68e-05	0.000608	CcSEcCtD
Fluorescein—Nausea—Conjugated Estrogens—prostate cancer	8.66e-05	0.000606	CcSEcCtD
Fluorescein—Urticaria—Mitoxantrone—prostate cancer	8.63e-05	0.000604	CcSEcCtD
Fluorescein—Hypersensitivity—Estradiol—prostate cancer	8.59e-05	0.000602	CcSEcCtD
Fluorescein—Abdominal pain—Mitoxantrone—prostate cancer	8.59e-05	0.000601	CcSEcCtD
Fluorescein—Hypotension—Etoposide—prostate cancer	8.45e-05	0.000591	CcSEcCtD
Fluorescein—Asthenia—Estradiol—prostate cancer	8.37e-05	0.000586	CcSEcCtD
Fluorescein—Tremor—Capecitabine—prostate cancer	8.35e-05	0.000585	CcSEcCtD
Fluorescein—Angiopathy—Prednisone—prostate cancer	8.27e-05	0.000579	CcSEcCtD
Fluorescein—Ill-defined disorder—Capecitabine—prostate cancer	8.27e-05	0.000579	CcSEcCtD
Fluorescein—Syncope—Docetaxel—prostate cancer	8.26e-05	0.000578	CcSEcCtD
Fluorescein—Pruritus—Estradiol—prostate cancer	8.25e-05	0.000578	CcSEcCtD
Fluorescein—Asthma—Doxorubicin—prostate cancer	8.25e-05	0.000577	CcSEcCtD
Fluorescein—Immune system disorder—Prednisone—prostate cancer	8.24e-05	0.000577	CcSEcCtD
Fluorescein—Paraesthesia—Etoposide—prostate cancer	8.12e-05	0.000568	CcSEcCtD
Fluorescein—Loss of consciousness—Docetaxel—prostate cancer	8.09e-05	0.000566	CcSEcCtD
Fluorescein—Dyspnoea—Etoposide—prostate cancer	8.06e-05	0.000564	CcSEcCtD
Fluorescein—Malaise—Capecitabine—prostate cancer	8.04e-05	0.000563	CcSEcCtD
Fluorescein—Cough—Docetaxel—prostate cancer	8.03e-05	0.000562	CcSEcCtD
Fluorescein—Angina pectoris—Doxorubicin—prostate cancer	8.03e-05	0.000562	CcSEcCtD
Fluorescein—Hypersensitivity—Mitoxantrone—prostate cancer	8.01e-05	0.000561	CcSEcCtD
Fluorescein—Syncope—Capecitabine—prostate cancer	7.99e-05	0.00056	CcSEcCtD
Fluorescein—Convulsion—Docetaxel—prostate cancer	7.98e-05	0.000558	CcSEcCtD
Fluorescein—Hypertension—Docetaxel—prostate cancer	7.95e-05	0.000556	CcSEcCtD
Fluorescein—Erythema—Prednisone—prostate cancer	7.94e-05	0.000556	CcSEcCtD
Fluorescein—Chest pain—Docetaxel—prostate cancer	7.84e-05	0.000549	CcSEcCtD
Fluorescein—Loss of consciousness—Capecitabine—prostate cancer	7.83e-05	0.000548	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Etoposide—prostate cancer	7.8e-05	0.000546	CcSEcCtD
Fluorescein—Asthenia—Mitoxantrone—prostate cancer	7.8e-05	0.000546	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	7.78e-05	0.000545	CcSEcCtD
Fluorescein—Cough—Capecitabine—prostate cancer	7.78e-05	0.000544	CcSEcCtD
Fluorescein—Pain—Etoposide—prostate cancer	7.73e-05	0.000541	CcSEcCtD
Fluorescein—Dizziness—Estradiol—prostate cancer	7.71e-05	0.00054	CcSEcCtD
Fluorescein—Hypertension—Capecitabine—prostate cancer	7.7e-05	0.000539	CcSEcCtD
Fluorescein—Chest pain—Capecitabine—prostate cancer	7.59e-05	0.000531	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.54e-05	0.000528	CcSEcCtD
Fluorescein—Oedema—Docetaxel—prostate cancer	7.51e-05	0.000526	CcSEcCtD
Fluorescein—Anaphylactic shock—Docetaxel—prostate cancer	7.51e-05	0.000526	CcSEcCtD
Fluorescein—Discomfort—Capecitabine—prostate cancer	7.5e-05	0.000525	CcSEcCtD
Fluorescein—Feeling abnormal—Etoposide—prostate cancer	7.45e-05	0.000522	CcSEcCtD
Fluorescein—Vomiting—Estradiol—prostate cancer	7.42e-05	0.000519	CcSEcCtD
Fluorescein—Gastrointestinal pain—Etoposide—prostate cancer	7.39e-05	0.000518	CcSEcCtD
Fluorescein—Shock—Docetaxel—prostate cancer	7.39e-05	0.000517	CcSEcCtD
Fluorescein—Nervous system disorder—Docetaxel—prostate cancer	7.37e-05	0.000516	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisone—prostate cancer	7.37e-05	0.000516	CcSEcCtD
Fluorescein—Rash—Estradiol—prostate cancer	7.35e-05	0.000515	CcSEcCtD
Fluorescein—Dermatitis—Estradiol—prostate cancer	7.35e-05	0.000514	CcSEcCtD
Fluorescein—Tachycardia—Docetaxel—prostate cancer	7.33e-05	0.000513	CcSEcCtD
Fluorescein—Headache—Estradiol—prostate cancer	7.31e-05	0.000512	CcSEcCtD
Fluorescein—Skin disorder—Docetaxel—prostate cancer	7.3e-05	0.000511	CcSEcCtD
Fluorescein—Oedema—Capecitabine—prostate cancer	7.27e-05	0.000509	CcSEcCtD
Fluorescein—Bradycardia—Epirubicin—prostate cancer	7.26e-05	0.000508	CcSEcCtD
Fluorescein—Urticaria—Etoposide—prostate cancer	7.18e-05	0.000503	CcSEcCtD
Fluorescein—Malaise—Prednisone—prostate cancer	7.16e-05	0.000501	CcSEcCtD
Fluorescein—Shock—Capecitabine—prostate cancer	7.16e-05	0.000501	CcSEcCtD
Fluorescein—Abdominal pain—Etoposide—prostate cancer	7.15e-05	0.0005	CcSEcCtD
Fluorescein—Nervous system disorder—Capecitabine—prostate cancer	7.13e-05	0.000499	CcSEcCtD
Fluorescein—Syncope—Prednisone—prostate cancer	7.12e-05	0.000498	CcSEcCtD
Fluorescein—Tachycardia—Capecitabine—prostate cancer	7.1e-05	0.000497	CcSEcCtD
Fluorescein—Hypoaesthesia—Epirubicin—prostate cancer	7.1e-05	0.000497	CcSEcCtD
Fluorescein—Skin disorder—Capecitabine—prostate cancer	7.07e-05	0.000495	CcSEcCtD
Fluorescein—Hyperhidrosis—Capecitabine—prostate cancer	7.03e-05	0.000492	CcSEcCtD
Fluorescein—Hypotension—Docetaxel—prostate cancer	7.02e-05	0.000491	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisone—prostate cancer	6.98e-05	0.000489	CcSEcCtD
Fluorescein—Nausea—Estradiol—prostate cancer	6.93e-05	0.000485	CcSEcCtD
Fluorescein—Vomiting—Mitoxantrone—prostate cancer	6.91e-05	0.000484	CcSEcCtD
Fluorescein—Convulsion—Prednisone—prostate cancer	6.88e-05	0.000482	CcSEcCtD
Fluorescein—Hypertension—Prednisone—prostate cancer	6.85e-05	0.00048	CcSEcCtD
Fluorescein—Rash—Mitoxantrone—prostate cancer	6.85e-05	0.00048	CcSEcCtD
Fluorescein—Dermatitis—Mitoxantrone—prostate cancer	6.85e-05	0.000479	CcSEcCtD
Fluorescein—Headache—Mitoxantrone—prostate cancer	6.81e-05	0.000477	CcSEcCtD
Fluorescein—Hypotension—Capecitabine—prostate cancer	6.8e-05	0.000476	CcSEcCtD
Fluorescein—Paraesthesia—Docetaxel—prostate cancer	6.75e-05	0.000472	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—prostate cancer	6.72e-05	0.00047	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.71e-05	0.00047	CcSEcCtD
Fluorescein—Dyspnoea—Docetaxel—prostate cancer	6.7e-05	0.000469	CcSEcCtD
Fluorescein—Discomfort—Prednisone—prostate cancer	6.68e-05	0.000468	CcSEcCtD
Fluorescein—Hypersensitivity—Etoposide—prostate cancer	6.66e-05	0.000466	CcSEcCtD
Fluorescein—Cardiac disorder—Epirubicin—prostate cancer	6.62e-05	0.000463	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—prostate cancer	6.57e-05	0.00046	CcSEcCtD
Fluorescein—Paraesthesia—Capecitabine—prostate cancer	6.53e-05	0.000457	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Docetaxel—prostate cancer	6.49e-05	0.000454	CcSEcCtD
Fluorescein—Asthenia—Etoposide—prostate cancer	6.49e-05	0.000454	CcSEcCtD
Fluorescein—Dyspnoea—Capecitabine—prostate cancer	6.49e-05	0.000454	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisone—prostate cancer	6.48e-05	0.000454	CcSEcCtD
Fluorescein—Oedema—Prednisone—prostate cancer	6.48e-05	0.000454	CcSEcCtD
Fluorescein—Angiopathy—Epirubicin—prostate cancer	6.47e-05	0.000453	CcSEcCtD
Fluorescein—Nausea—Mitoxantrone—prostate cancer	6.46e-05	0.000452	CcSEcCtD
Fluorescein—Immune system disorder—Epirubicin—prostate cancer	6.44e-05	0.000451	CcSEcCtD
Fluorescein—Mediastinal disorder—Epirubicin—prostate cancer	6.43e-05	0.00045	CcSEcCtD
Fluorescein—Pain—Docetaxel—prostate cancer	6.42e-05	0.00045	CcSEcCtD
Fluorescein—Chills—Epirubicin—prostate cancer	6.4e-05	0.000448	CcSEcCtD
Fluorescein—Pruritus—Etoposide—prostate cancer	6.4e-05	0.000448	CcSEcCtD
Fluorescein—Shock—Prednisone—prostate cancer	6.37e-05	0.000446	CcSEcCtD
Fluorescein—Nervous system disorder—Prednisone—prostate cancer	6.35e-05	0.000445	CcSEcCtD
Fluorescein—Tachycardia—Prednisone—prostate cancer	6.32e-05	0.000443	CcSEcCtD
Fluorescein—Skin disorder—Prednisone—prostate cancer	6.29e-05	0.000441	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Capecitabine—prostate cancer	6.28e-05	0.00044	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisone—prostate cancer	6.26e-05	0.000439	CcSEcCtD
Fluorescein—Pain—Capecitabine—prostate cancer	6.22e-05	0.000435	CcSEcCtD
Fluorescein—Erythema—Epirubicin—prostate cancer	6.21e-05	0.000435	CcSEcCtD
Fluorescein—Feeling abnormal—Docetaxel—prostate cancer	6.19e-05	0.000433	CcSEcCtD
Fluorescein—Gastrointestinal pain—Docetaxel—prostate cancer	6.14e-05	0.00043	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—prostate cancer	6.13e-05	0.000429	CcSEcCtD
Fluorescein—Dysgeusia—Epirubicin—prostate cancer	6.08e-05	0.000426	CcSEcCtD
Fluorescein—Feeling abnormal—Capecitabine—prostate cancer	5.99e-05	0.00042	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—prostate cancer	5.99e-05	0.000419	CcSEcCtD
Fluorescein—Dizziness—Etoposide—prostate cancer	5.98e-05	0.000419	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—prostate cancer	5.96e-05	0.000417	CcSEcCtD
Fluorescein—Gastrointestinal pain—Capecitabine—prostate cancer	5.95e-05	0.000416	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—prostate cancer	5.95e-05	0.000416	CcSEcCtD
Fluorescein—Abdominal pain—Docetaxel—prostate cancer	5.94e-05	0.000416	CcSEcCtD
Fluorescein—Chills—Doxorubicin—prostate cancer	5.92e-05	0.000415	CcSEcCtD
Fluorescein—Paraesthesia—Prednisone—prostate cancer	5.82e-05	0.000407	CcSEcCtD
Fluorescein—Urticaria—Capecitabine—prostate cancer	5.78e-05	0.000405	CcSEcCtD
Fluorescein—Ill-defined disorder—Epirubicin—prostate cancer	5.76e-05	0.000403	CcSEcCtD
Fluorescein—Abdominal pain—Capecitabine—prostate cancer	5.75e-05	0.000403	CcSEcCtD
Fluorescein—Vomiting—Etoposide—prostate cancer	5.75e-05	0.000402	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—prostate cancer	5.75e-05	0.000402	CcSEcCtD
Fluorescein—Rash—Etoposide—prostate cancer	5.7e-05	0.000399	CcSEcCtD
Fluorescein—Dermatitis—Etoposide—prostate cancer	5.69e-05	0.000399	CcSEcCtD
Fluorescein—Headache—Etoposide—prostate cancer	5.66e-05	0.000396	CcSEcCtD
Fluorescein—Dysgeusia—Doxorubicin—prostate cancer	5.63e-05	0.000394	CcSEcCtD
Fluorescein—Malaise—Epirubicin—prostate cancer	5.6e-05	0.000392	CcSEcCtD
Fluorescein—Syncope—Epirubicin—prostate cancer	5.57e-05	0.00039	CcSEcCtD
Fluorescein—Hypersensitivity—Docetaxel—prostate cancer	5.54e-05	0.000388	CcSEcCtD
Fluorescein—Loss of consciousness—Epirubicin—prostate cancer	5.46e-05	0.000382	CcSEcCtD
Fluorescein—Cough—Epirubicin—prostate cancer	5.42e-05	0.000379	CcSEcCtD
Fluorescein—Asthenia—Docetaxel—prostate cancer	5.39e-05	0.000377	CcSEcCtD
Fluorescein—Convulsion—Epirubicin—prostate cancer	5.38e-05	0.000377	CcSEcCtD
Fluorescein—Nausea—Etoposide—prostate cancer	5.37e-05	0.000376	CcSEcCtD
Fluorescein—Hypertension—Epirubicin—prostate cancer	5.36e-05	0.000375	CcSEcCtD
Fluorescein—Hypersensitivity—Capecitabine—prostate cancer	5.36e-05	0.000375	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisone—prostate cancer	5.34e-05	0.000374	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—prostate cancer	5.33e-05	0.000373	CcSEcCtD
Fluorescein—Pruritus—Docetaxel—prostate cancer	5.32e-05	0.000372	CcSEcCtD
Fluorescein—Gastrointestinal pain—Prednisone—prostate cancer	5.3e-05	0.000371	CcSEcCtD
Fluorescein—Chest pain—Epirubicin—prostate cancer	5.29e-05	0.00037	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.25e-05	0.000368	CcSEcCtD
Fluorescein—Discomfort—Epirubicin—prostate cancer	5.22e-05	0.000366	CcSEcCtD
Fluorescein—Asthenia—Capecitabine—prostate cancer	5.22e-05	0.000365	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—prostate cancer	5.18e-05	0.000363	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—prostate cancer	5.15e-05	0.000361	CcSEcCtD
Fluorescein—Urticaria—Prednisone—prostate cancer	5.15e-05	0.00036	CcSEcCtD
Fluorescein—Pruritus—Capecitabine—prostate cancer	5.15e-05	0.00036	CcSEcCtD
Fluorescein—Abdominal pain—Prednisone—prostate cancer	5.12e-05	0.000359	CcSEcCtD
Fluorescein—Anaphylactic shock—Epirubicin—prostate cancer	5.07e-05	0.000355	CcSEcCtD
Fluorescein—Oedema—Epirubicin—prostate cancer	5.07e-05	0.000355	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—prostate cancer	5.05e-05	0.000354	CcSEcCtD
Fluorescein—Cough—Doxorubicin—prostate cancer	5.01e-05	0.000351	CcSEcCtD
Fluorescein—Shock—Epirubicin—prostate cancer	4.99e-05	0.000349	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—prostate cancer	4.98e-05	0.000348	CcSEcCtD
Fluorescein—Nervous system disorder—Epirubicin—prostate cancer	4.97e-05	0.000348	CcSEcCtD
Fluorescein—Dizziness—Docetaxel—prostate cancer	4.97e-05	0.000348	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—prostate cancer	4.96e-05	0.000347	CcSEcCtD
Fluorescein—Tachycardia—Epirubicin—prostate cancer	4.95e-05	0.000346	CcSEcCtD
Fluorescein—Skin disorder—Epirubicin—prostate cancer	4.92e-05	0.000345	CcSEcCtD
Fluorescein—Hyperhidrosis—Epirubicin—prostate cancer	4.9e-05	0.000343	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—prostate cancer	4.89e-05	0.000342	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.86e-05	0.00034	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—prostate cancer	4.83e-05	0.000338	CcSEcCtD
Fluorescein—Dizziness—Capecitabine—prostate cancer	4.81e-05	0.000337	CcSEcCtD
Fluorescein—Vomiting—Docetaxel—prostate cancer	4.78e-05	0.000334	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisone—prostate cancer	4.77e-05	0.000334	CcSEcCtD
Fluorescein—Rash—Docetaxel—prostate cancer	4.74e-05	0.000332	CcSEcCtD
Fluorescein—Hypotension—Epirubicin—prostate cancer	4.74e-05	0.000332	CcSEcCtD
Fluorescein—Dermatitis—Docetaxel—prostate cancer	4.73e-05	0.000331	CcSEcCtD
Fluorescein—Headache—Docetaxel—prostate cancer	4.71e-05	0.00033	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—prostate cancer	4.69e-05	0.000328	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—prostate cancer	4.69e-05	0.000328	CcSEcCtD
Fluorescein—Asthenia—Prednisone—prostate cancer	4.65e-05	0.000325	CcSEcCtD
Fluorescein—Vomiting—Capecitabine—prostate cancer	4.63e-05	0.000324	CcSEcCtD
Fluorescein—Shock—Doxorubicin—prostate cancer	4.61e-05	0.000323	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—prostate cancer	4.6e-05	0.000322	CcSEcCtD
Fluorescein—Rash—Capecitabine—prostate cancer	4.59e-05	0.000321	CcSEcCtD
Fluorescein—Pruritus—Prednisone—prostate cancer	4.58e-05	0.000321	CcSEcCtD
Fluorescein—Dermatitis—Capecitabine—prostate cancer	4.58e-05	0.000321	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—prostate cancer	4.58e-05	0.00032	CcSEcCtD
Fluorescein—Headache—Capecitabine—prostate cancer	4.56e-05	0.000319	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—prostate cancer	4.55e-05	0.000319	CcSEcCtD
Fluorescein—Paraesthesia—Epirubicin—prostate cancer	4.55e-05	0.000319	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—prostate cancer	4.53e-05	0.000317	CcSEcCtD
Fluorescein—Dyspnoea—Epirubicin—prostate cancer	4.52e-05	0.000316	CcSEcCtD
Fluorescein—Nausea—Docetaxel—prostate cancer	4.46e-05	0.000312	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—prostate cancer	4.38e-05	0.000307	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Epirubicin—prostate cancer	4.38e-05	0.000306	CcSEcCtD
Fluorescein—Pain—Epirubicin—prostate cancer	4.33e-05	0.000303	CcSEcCtD
Fluorescein—Nausea—Capecitabine—prostate cancer	4.32e-05	0.000302	CcSEcCtD
Fluorescein—Dizziness—Prednisone—prostate cancer	4.28e-05	0.0003	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—prostate cancer	4.21e-05	0.000295	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—prostate cancer	4.18e-05	0.000293	CcSEcCtD
Fluorescein—Feeling abnormal—Epirubicin—prostate cancer	4.18e-05	0.000292	CcSEcCtD
Fluorescein—Gastrointestinal pain—Epirubicin—prostate cancer	4.14e-05	0.00029	CcSEcCtD
Fluorescein—Vomiting—Prednisone—prostate cancer	4.12e-05	0.000288	CcSEcCtD
Fluorescein—Rash—Prednisone—prostate cancer	4.09e-05	0.000286	CcSEcCtD
Fluorescein—Dermatitis—Prednisone—prostate cancer	4.08e-05	0.000286	CcSEcCtD
Fluorescein—Headache—Prednisone—prostate cancer	4.06e-05	0.000284	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.05e-05	0.000283	CcSEcCtD
Fluorescein—Urticaria—Epirubicin—prostate cancer	4.03e-05	0.000282	CcSEcCtD
Fluorescein—Pain—Doxorubicin—prostate cancer	4.01e-05	0.000281	CcSEcCtD
Fluorescein—Abdominal pain—Epirubicin—prostate cancer	4.01e-05	0.00028	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—prostate cancer	3.86e-05	0.000271	CcSEcCtD
Fluorescein—Nausea—Prednisone—prostate cancer	3.85e-05	0.000269	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—prostate cancer	3.83e-05	0.000268	CcSEcCtD
Fluorescein—Hypersensitivity—Epirubicin—prostate cancer	3.73e-05	0.000261	CcSEcCtD
Fluorescein—Urticaria—Doxorubicin—prostate cancer	3.73e-05	0.000261	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—prostate cancer	3.71e-05	0.000259	CcSEcCtD
Fluorescein—Asthenia—Epirubicin—prostate cancer	3.64e-05	0.000255	CcSEcCtD
Fluorescein—Pruritus—Epirubicin—prostate cancer	3.59e-05	0.000251	CcSEcCtD
Fluorescein—Hypersensitivity—Doxorubicin—prostate cancer	3.45e-05	0.000242	CcSEcCtD
Fluorescein—Asthenia—Doxorubicin—prostate cancer	3.36e-05	0.000236	CcSEcCtD
Fluorescein—Dizziness—Epirubicin—prostate cancer	3.35e-05	0.000235	CcSEcCtD
Fluorescein—Pruritus—Doxorubicin—prostate cancer	3.32e-05	0.000232	CcSEcCtD
Fluorescein—Vomiting—Epirubicin—prostate cancer	3.22e-05	0.000226	CcSEcCtD
Fluorescein—Rash—Epirubicin—prostate cancer	3.2e-05	0.000224	CcSEcCtD
Fluorescein—Dermatitis—Epirubicin—prostate cancer	3.19e-05	0.000223	CcSEcCtD
Fluorescein—Headache—Epirubicin—prostate cancer	3.17e-05	0.000222	CcSEcCtD
Fluorescein—Dizziness—Doxorubicin—prostate cancer	3.1e-05	0.000217	CcSEcCtD
Fluorescein—Nausea—Epirubicin—prostate cancer	3.01e-05	0.000211	CcSEcCtD
Fluorescein—Vomiting—Doxorubicin—prostate cancer	2.98e-05	0.000209	CcSEcCtD
Fluorescein—Rash—Doxorubicin—prostate cancer	2.96e-05	0.000207	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—prostate cancer	2.95e-05	0.000207	CcSEcCtD
Fluorescein—Headache—Doxorubicin—prostate cancer	2.94e-05	0.000206	CcSEcCtD
Fluorescein—Nausea—Doxorubicin—prostate cancer	2.79e-05	0.000195	CcSEcCtD
Fluorescein—ABCC1—Metabolism—P4HB—prostate cancer	1.75e-05	0.000222	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.74e-05	0.000221	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NCOA2—prostate cancer	1.74e-05	0.00022	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—B4GALT4—prostate cancer	1.72e-05	0.000218	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HPGD—prostate cancer	1.72e-05	0.000218	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SLC22A1—prostate cancer	1.71e-05	0.000216	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.71e-05	0.000216	CbGpPWpGaD
Fluorescein—ABCC1—Disease—B2M—prostate cancer	1.69e-05	0.000214	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TGFBR1—prostate cancer	1.69e-05	0.000214	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.69e-05	0.000213	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SULT2A1—prostate cancer	1.66e-05	0.00021	CbGpPWpGaD
Fluorescein—ABCC1—Disease—RPS19—prostate cancer	1.66e-05	0.00021	CbGpPWpGaD
Fluorescein—ABCC1—Disease—AKR1C3—prostate cancer	1.66e-05	0.00021	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—SLC5A5—prostate cancer	1.66e-05	0.00021	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PRKACB—prostate cancer	1.65e-05	0.000209	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—MED12—prostate cancer	1.64e-05	0.000207	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GNG5—prostate cancer	1.62e-05	0.000205	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TNFRSF21—prostate cancer	1.62e-05	0.000205	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP2E1—prostate cancer	1.62e-05	0.000205	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PPP3CA—prostate cancer	1.61e-05	0.000204	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NQO1—prostate cancer	1.6e-05	0.000203	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP7B1—prostate cancer	1.58e-05	0.0002	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MTAP—prostate cancer	1.58e-05	0.0002	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—TH—prostate cancer	1.58e-05	0.0002	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.57e-05	0.000198	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NCOA3—prostate cancer	1.56e-05	0.000198	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP3A4—prostate cancer	1.56e-05	0.000198	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PRKCZ—prostate cancer	1.56e-05	0.000197	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.55e-05	0.000197	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.54e-05	0.000195	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SRD5A1—prostate cancer	1.54e-05	0.000195	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SULT1E1—prostate cancer	1.54e-05	0.000195	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.54e-05	0.000194	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP1B1—prostate cancer	1.53e-05	0.000194	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CALR—prostate cancer	1.53e-05	0.000194	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGFR4—prostate cancer	1.5e-05	0.00019	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PARP1—prostate cancer	1.5e-05	0.00019	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.49e-05	0.000189	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—HPGDS—prostate cancer	1.49e-05	0.000189	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CALCA—prostate cancer	1.49e-05	0.000188	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GGT1—prostate cancer	1.49e-05	0.000188	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP2C19—prostate cancer	1.48e-05	0.000188	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.47e-05	0.000186	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HSD17B3—prostate cancer	1.47e-05	0.000186	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ACSL4—prostate cancer	1.47e-05	0.000186	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NCOA1—prostate cancer	1.46e-05	0.000185	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—prostate cancer	1.45e-05	0.000184	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.45e-05	0.000183	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ACHE—prostate cancer	1.45e-05	0.000183	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTT1—prostate cancer	1.45e-05	0.000183	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP19A1—prostate cancer	1.44e-05	0.000183	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP2A6—prostate cancer	1.43e-05	0.000181	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HSPA1A—prostate cancer	1.42e-05	0.00018	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.42e-05	0.00018	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.41e-05	0.000179	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PHGDH—prostate cancer	1.41e-05	0.000178	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ARG2—prostate cancer	1.41e-05	0.000178	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—UMPS—prostate cancer	1.41e-05	0.000178	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.4e-05	0.000177	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—RXRA—prostate cancer	1.39e-05	0.000176	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—AKR1C3—prostate cancer	1.39e-05	0.000176	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PRKACB—prostate cancer	1.38e-05	0.000175	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—LDHB—prostate cancer	1.38e-05	0.000175	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP17A1—prostate cancer	1.37e-05	0.000173	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CASP9—prostate cancer	1.37e-05	0.000173	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.35e-05	0.000171	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.35e-05	0.000171	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP3A5—prostate cancer	1.35e-05	0.000171	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.35e-05	0.000171	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—COMT—prostate cancer	1.34e-05	0.00017	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTP1—prostate cancer	1.33e-05	0.000169	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PRKCQ—prostate cancer	1.32e-05	0.000168	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ITPR1—prostate cancer	1.31e-05	0.000166	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PDHA1—prostate cancer	1.31e-05	0.000165	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TCN2—prostate cancer	1.31e-05	0.000165	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTA3—prostate cancer	1.31e-05	0.000165	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—UCP3—prostate cancer	1.31e-05	0.000165	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NCOA2—prostate cancer	1.3e-05	0.000165	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.29e-05	0.000163	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGF10—prostate cancer	1.26e-05	0.000159	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HSD3B1—prostate cancer	1.25e-05	0.000158	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SLC22A3—prostate cancer	1.25e-05	0.000158	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SLC5A5—prostate cancer	1.24e-05	0.000158	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—TYMS—prostate cancer	1.24e-05	0.000157	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTM1—prostate cancer	1.23e-05	0.000155	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP2E1—prostate cancer	1.22e-05	0.000154	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.21e-05	0.000153	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—LPL—prostate cancer	1.2e-05	0.000152	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NQO1—prostate cancer	1.2e-05	0.000152	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TGFBR2—prostate cancer	1.2e-05	0.000152	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTA4—prostate cancer	1.19e-05	0.000151	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TBXAS1—prostate cancer	1.19e-05	0.000151	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—TH—prostate cancer	1.18e-05	0.00015	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ITPR1—prostate cancer	1.18e-05	0.000149	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.18e-05	0.000149	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP3A4—prostate cancer	1.17e-05	0.000148	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.17e-05	0.000148	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTA2—prostate cancer	1.16e-05	0.000147	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP1A1—prostate cancer	1.16e-05	0.000147	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ERCC2—prostate cancer	1.15e-05	0.000146	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP1B1—prostate cancer	1.15e-05	0.000146	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ABCG5—prostate cancer	1.15e-05	0.000146	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SULT1A1—prostate cancer	1.15e-05	0.000146	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTA1—prostate cancer	1.12e-05	0.000142	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GGT1—prostate cancer	1.12e-05	0.000141	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTO1—prostate cancer	1.11e-05	0.000141	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HSD3B2—prostate cancer	1.11e-05	0.000141	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NAT2—prostate cancer	1.11e-05	0.000141	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NCOA1—prostate cancer	1.1e-05	0.000139	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—MTHFR—prostate cancer	1.08e-05	0.000137	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP19A1—prostate cancer	1.08e-05	0.000137	CbGpPWpGaD
Fluorescein—ABCC1—Disease—LPL—prostate cancer	1.08e-05	0.000137	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PDGFRB—prostate cancer	1.07e-05	0.000135	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.07e-05	0.000135	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PLCB2—prostate cancer	1.07e-05	0.000135	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—LRP2—prostate cancer	1.07e-05	0.000135	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP2C18—prostate cancer	1.07e-05	0.000135	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PPARA—prostate cancer	1.06e-05	0.000135	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—RXRA—prostate cancer	1.05e-05	0.000132	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—P4HB—prostate cancer	1.04e-05	0.000132	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ERCC2—prostate cancer	1.03e-05	0.000131	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.02e-05	0.000129	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SLC22A1—prostate cancer	1.02e-05	0.000129	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ERBB3—prostate cancer	1.01e-05	0.000128	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGFR2—prostate cancer	1.01e-05	0.000128	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—COMT—prostate cancer	1.01e-05	0.000128	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1e-05	0.000127	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTP1—prostate cancer	1e-05	0.000127	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CAV1—prostate cancer	1e-05	0.000127	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SULT2A1—prostate cancer	9.9e-06	0.000125	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ITPR1—prostate cancer	9.86e-06	0.000125	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MED12—prostate cancer	9.74e-06	0.000123	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MTHFR—prostate cancer	9.72e-06	0.000123	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.7e-06	0.000123	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TERT—prostate cancer	9.69e-06	0.000123	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GNG5—prostate cancer	9.66e-06	0.000122	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.55e-06	0.000121	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—TYMS—prostate cancer	9.32e-06	0.000118	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NCOA3—prostate cancer	9.31e-06	0.000118	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HIF1A—prostate cancer	9.27e-06	0.000117	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTM1—prostate cancer	9.21e-06	0.000117	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	9.15e-06	0.000116	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CG—prostate cancer	9.11e-06	0.000115	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—LPL—prostate cancer	9.04e-06	0.000114	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CAV1—prostate cancer	8.97e-06	0.000114	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HPGDS—prostate cancer	8.88e-06	0.000112	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP2C19—prostate cancer	8.83e-06	0.000112	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP1A1—prostate cancer	8.73e-06	0.000111	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ERCC2—prostate cancer	8.66e-06	0.00011	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—INS—prostate cancer	8.62e-06	0.000109	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTT1—prostate cancer	8.61e-06	0.000109	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ACHE—prostate cancer	8.61e-06	0.000109	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP2A6—prostate cancer	8.51e-06	0.000108	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	8.48e-06	0.000107	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CREBBP—prostate cancer	8.44e-06	0.000107	CbGpPWpGaD
Fluorescein—ABCC1—Disease—BAD—prostate cancer	8.43e-06	0.000107	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—AKR1C3—prostate cancer	8.28e-06	0.000105	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PRKACB—prostate cancer	8.24e-06	0.000104	CbGpPWpGaD
Fluorescein—ABCC1—Disease—APC—prostate cancer	8.17e-06	0.000103	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP17A1—prostate cancer	8.15e-06	0.000103	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—MTHFR—prostate cancer	8.14e-06	0.000103	CbGpPWpGaD
Fluorescein—ABCC1—Disease—EGF—prostate cancer	8.07e-06	0.000102	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IRS1—prostate cancer	8.07e-06	0.000102	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	8.04e-06	0.000102	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CD—prostate cancer	8e-06	0.000101	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PPARA—prostate cancer	7.99e-06	0.000101	CbGpPWpGaD
Fluorescein—ABCC1—Disease—GSK3B—prostate cancer	7.84e-06	9.92e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NCOA2—prostate cancer	7.77e-06	9.84e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—INS—prostate cancer	7.73e-06	9.79e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CREBBP—prostate cancer	7.57e-06	9.59e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NOS3—prostate cancer	7.56e-06	9.57e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CAV1—prostate cancer	7.51e-06	9.51e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SLC5A5—prostate cancer	7.41e-06	9.39e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP2E1—prostate cancer	7.24e-06	9.17e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MAP2K1—prostate cancer	7.23e-06	9.15e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PIK3CD—prostate cancer	7.18e-06	9.09e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.17e-06	9.08e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NQO1—prostate cancer	7.16e-06	9.06e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SERPINE1—prostate cancer	7.1e-06	8.99e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TH—prostate cancer	7.06e-06	8.93e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.01e-06	8.88e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP3A4—prostate cancer	6.98e-06	8.84e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CB—prostate cancer	6.98e-06	8.83e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.95e-06	8.79e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PTGS2—prostate cancer	6.91e-06	8.75e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGF2—prostate cancer	6.87e-06	8.7e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP1B1—prostate cancer	6.86e-06	8.69e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CG—prostate cancer	6.84e-06	8.66e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NOS3—prostate cancer	6.78e-06	8.58e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GGT1—prostate cancer	6.65e-06	8.42e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—JAK2—prostate cancer	6.59e-06	8.34e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NCOA1—prostate cancer	6.55e-06	8.29e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—INS—prostate cancer	6.47e-06	8.2e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP19A1—prostate cancer	6.45e-06	8.17e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MDM2—prostate cancer	6.43e-06	8.14e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CREBBP—prostate cancer	6.34e-06	8.03e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ERBB2—prostate cancer	6.34e-06	8.03e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PIK3CB—prostate cancer	6.26e-06	7.92e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—RXRA—prostate cancer	6.23e-06	7.89e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PTGS2—prostate cancer	6.2e-06	7.85e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.06e-06	7.67e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PTEN—prostate cancer	6.03e-06	7.63e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CD—prostate cancer	6.01e-06	7.61e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—COMT—prostate cancer	6e-06	7.6e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTP1—prostate cancer	5.97e-06	7.56e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ITPR1—prostate cancer	5.88e-06	7.44e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CDKN1B—prostate cancer	5.87e-06	7.44e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.78e-06	7.31e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—EP300—prostate cancer	5.75e-06	7.28e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NOS3—prostate cancer	5.68e-06	7.19e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TYMS—prostate cancer	5.55e-06	7.03e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CTNNB1—prostate cancer	5.55e-06	7.03e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTM1—prostate cancer	5.49e-06	6.95e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CDKN1A—prostate cancer	5.42e-06	6.86e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PTEN—prostate cancer	5.41e-06	6.85e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—LPL—prostate cancer	5.39e-06	6.82e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CB—prostate cancer	5.24e-06	6.64e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PTGS2—prostate cancer	5.19e-06	6.58e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ERCC2—prostate cancer	5.16e-06	6.53e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—EP300—prostate cancer	5.16e-06	6.53e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SRC—prostate cancer	5.02e-06	6.35e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MTHFR—prostate cancer	4.85e-06	6.14e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—STAT3—prostate cancer	4.84e-06	6.12e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PPARA—prostate cancer	4.76e-06	6.02e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PTEN—prostate cancer	4.53e-06	5.73e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MYC—prostate cancer	4.49e-06	5.69e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TGFB1—prostate cancer	4.48e-06	5.68e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CAV1—prostate cancer	4.47e-06	5.66e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—EGFR—prostate cancer	4.4e-06	5.57e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—EP300—prostate cancer	4.32e-06	5.47e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.27e-06	5.41e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PIK3CA—prostate cancer	4.25e-06	5.39e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—KRAS—prostate cancer	4.15e-06	5.26e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CG—prostate cancer	4.07e-06	5.16e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—INS—prostate cancer	3.86e-06	4.88e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PIK3CA—prostate cancer	3.82e-06	4.83e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CREBBP—prostate cancer	3.78e-06	4.78e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CD—prostate cancer	3.58e-06	4.53e-05	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—AKT1—prostate cancer	3.47e-06	4.4e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NOS3—prostate cancer	3.38e-06	4.28e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IL6—prostate cancer	3.38e-06	4.28e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PIK3CA—prostate cancer	3.2e-06	4.05e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CB—prostate cancer	3.12e-06	3.95e-05	CbGpPWpGaD
Fluorescein—ABCC1—Disease—AKT1—prostate cancer	3.12e-06	3.95e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PTGS2—prostate cancer	3.09e-06	3.92e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PTEN—prostate cancer	2.7e-06	3.42e-05	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—AKT1—prostate cancer	2.61e-06	3.3e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—EP300—prostate cancer	2.57e-06	3.26e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.9e-06	2.41e-05	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—AKT1—prostate cancer	1.55e-06	1.97e-05	CbGpPWpGaD
